Molecular Subtype

Triple-Negative Breast Carcinoma

416 active trials3 approved drugs8 evidence items

NCIt: C71732
DOID: 0060081
MeSH: D064726

Clinical trials

Registered studies

948 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 416
Recruiting: 234
Ph III recruiting: 21
Growth YoY: +2.4%
Industry share: 31%
Top sponsor: Fudan University
Termination share: 47%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (167)

No study matches these filters